Global partnerships formed during the Covid-19 era

Coronavirus brings attention to next-generation sequencing for genomic surveillance.

Read more here

New multiomics and big data for predictive genomics

Latest techniques in predictive medicine transform healthcare from a reactive to a preemptive approach.

Secure your place

Next-generation sequencing for companion diagnostics

Hear the latest case studies in personalised medicine and the future of healthcare.

View the latest program

Who should attend

  • Genomics Research
  • Next-Generation Sequencing
  • Business Development
  • Translational Research
  • Immuno-Oncology
  • Clinical Trials and Approvals
  • Multiomics Research
  • Biotechnology Research
  • Manufacturing Research & Innovation
  • Clinical Diagnostics
  • Pathology
  • Research and Development
  • Companion Diagnostics
  • Bio-Surveillance
  • Strategy, Projects, & Public Affairs
  • Clinical Trials
  • Spatial Biology
  • Sales and Marketing Initiatives
  • Epidemiology
  • System Biology and Research
  • Legal and Regulatory
  • Bioinformatics
  • Precision Medicine
  • Equipment Certification Services
  • Molecular Medicine
  • Laboratory Equipment
  • News Reporting and Journalism
  • Biotechnology Companies
  • Genomic and Pathology Laboratories
  • Associations and Alliances
  • Pharmaceutical Companies
  • Clinical Research Organizations
  • Universities and Academia
  • Biopharmaceutical Companies
  • Precision Medicine Researchers
  • Research and Development
  • Diagnostic Companies
  • NGS Equipment Manufacturers
  • Government Agencies
  • Global Healthcare Providers
  • Omics Research Companies
  • Consultants and Advisors
  • Next-Generation Sequencing Companies
  • Spatial Biology Companies
  • Public Consultation Groups
  • Cancer Research & Treatment
  • Molecular Medicine Companies
  • Legal and Compliance Services
  • Translational Research Companies
  • Non-Governmental Organisations
  • News Reporters and Journalists

Expert Speakers to Date

  • Kalotina Machini
    Partners HealthCare
  • Gina Fioretti
    Recuro Health
  • Philip Beer
    Step Pharma
  • Thomas Ayers
    Dolomite Bio
  • Clara Rodriguez
    Dolomite Bio
  • Joanne Hackett
  • Eric B. Kmiec
    Gene Editing Institute
  • Arvind Rao
    Regents of the University of Michigan
  • Sven Nahnsen
    University of Tübingen

Why Attend

Future Genomics 2023 is the only event of its kind to deliver leading market intelligence and industry presentations on the latest in multiomics, next-generation sequencing, and diagnostics for the advancement of global healthcare…

view more...

Subscribe for updates:

Exclusive Forum for Next-Generation Sequencing and the Future of Genomics

Welcome to Future Genomics 2023, where global biotech, pharmaceutical, and diagnostic companies will meet with leading researchers to explore the latest developments in genomics, multiomics, and clinical diagnostics. This world-class event will showcase innovation and demonstrate success to ensure that new innovations in next-generation sequencing enter the clinic with speed and accuracy.

Next-Generation Sequencing (NGS) and predictive genomics have proven to be invaluable resources for managing diseases and have allowed researchers to quickly gain insight into the genetic nature of pathogens at the heart of active outbreaks.

Globally, large-scale genomics and big data can enable transmission mapping for infection control and ultimately prevent diseases and future pandemics. In addition, it can distinguish independent cases from active clusters and identify epidemiological patterns in time and space on both local and global scales.

This year’s Future Genomics 2023 event is set to become the world’s leading exhibition and conference exclusively for the biotech, pharmaceutical, and diagnostics industries. Leaders will meet and collaborate with a large array of experts to examine the latest developments in multiomics and next-generation sequencing technologies to advance global healthcare.

Key topics on this year’s agenda include:

  • The fundamentals of next-generation sequencing and predictive genomics
  • New technologies and techniques in genomics and companion diagnostics
  • Latest research and studies in genomic biomarker-based clinical trials
  • New developments in multiomics technologies and precision medicine
  • Advances in companion diagnostics for immuno-oncology therapies
  • Towards a genomics-based, real-time, global surveillance system

This event will provide a forum for all stakeholders across the industry to network and build cross-market relationships to explore new technologies and technical know-how in multiomics and next-generation sequencing to address the challenges in the advancement of healthcare.

Call for Presentation

If you would like to be a speaker at this event, please contact sean.collins@iQ-Hub.com, subject heading “Call for Papers - Future Genomics 2023”

Book now
To secure your place at Future Genomics 2023, or if you require more information, please contact delegates@iQ-Hub.com.

Key topics for 2023:

  • The fundamentals of next-generation sequencing and predictive genomics
    Understanding how the sequence of a genome is being used for predictive medicine in clinical diagnostics and epidemiological studies.
  • New technologies and techniques in genomics and companion diagnostics
    Look for the latest developments in laboratory equipment and testing for clinical decision-making by expert analysts, physicians, and molecular pathologists.
  • Latest research and studies in genomic biomarker-based clinical trials
    Explore new innovations in multigene markers that predict diseases more accurately than classical methods and can be used for translational therapeutics.
  • New developments in multiomics technologies and precision medicine
    Future integration of multiomics to facilitate a paradigm shift to personalised medicine, as well as reference-free analysis, lineage tracing, identifying new cell types, and deciphering the regulatory mechanisms between omics.
  • Advances in companion diagnostics for immuno-oncology therapies
    Facilitate collaboration between pharma and diagnostic companies and bring together immuno-oncologist and translational experts to review the tools and strategies to advance immunotherapies.
  • Towards a genomics-based, real-time, global surveillance system
    Enabling international genomics collaboration for global health security by monitoring pathogen evolution and massive population-level projects.
Back to Top


IQ Hub is committed to running this event responsibly. We believe in the power of live events and are determined to provide the most content-rich agenda and enhanced networking opportunities for our attendees.

Throughout the COVID-19 pandemic we have monitored guidance from health officials and governments for best practices. We have consulted with other event industry professionals to enhance the safety of our registration, exhibition, and conference areas.

From check-in to session rooms, exhibit halls, meals and networking, we have taken specific steps to help you feel secure and to ensure your own safety. All new procedures are designed to help prevent transmission and to maintain physical distancing during the event.

  • All attendees will be requested to wear face masks

  • Temperature checks using non-contact thermometers

  • Hand sanitizer stations placed throughout the event area

  • Gloves provided for anyone who would like to wear them

  • Seating plan with fewer attendees per table to ensure distance

  • Tables spaced out further in conference and session rooms

  • Increased cleaning and disinfecting of high-touch areas

  • Floor markings throughout the event to direct traffic

Beyond these measures, there may be additional, venue-specific safety procedures. Please visit each venue’s web site for complete information before you travel to the event as they are subject to change with little notice. If you have any further suggestions, please send them via email to delegates@iQ-Hub.com.

Stay tuned to this website, or contact us to join the email list for the latest information.